Amneal Pharmaceuticals launches bimatoprost ophthalmic solution 0.01% (2.5 mL, 5 mL, and 7.5 mL). The product is the generic equivalent of LUMIGAN (bimatoprost ophthalmic solution) 0.01%, a trademark of Allergan, an AbbVie company. Bimatoprost ophthalmic solution 0.01% is a prostaglandin analog indicated for the reduction of elevated intraocular pressure in patients with open-angle glaucoma or ocular hypertension. The most common adverse reaction associated with bimatoprost ophthalmic solution 0.01% is conjunctival hyperemia. For prescribing information, refer to the package insert.